Skip to main content
. 2021 Oct 19;12(11):1739–1744. doi: 10.1021/acsmedchemlett.1c00369

Table 2. Radioactivity Distribution 30 min Post-injection Determined by Counting after Dissection.

  Uptake index (±SEM)
  Uptake inhibition (%)d
Tissue or BS Baseline conditions blocking with naloxonea blocking with U50,488b blocking with JDTicc BS/CB ratio (baseline) naloxone U50,488 JDTic
Blood 0.25 ± 0.04 0.33 ± 0.09 0.24 ± 0.03 0.27 ± 0.04 nae nae nae nae
Pituitary 8.06 ± 0.28 5.58 ± 0.48 5.61 ± 0.19 4.59 ± 0.67 nae 31 30 43
1/2 Brain 0.06 ± 0.01 0.05 ± 0.01 0.05 ± 0.01 0.06 ± 0.01 nae      
HY 0.23 ± 0.07 0.17 ± 0.02 0.13 ± 0.02 0.17 ± 0.02 3.70 ± 1.31   43  
OT 0.15 ± 0.03 0.17 ± 0.08 0.09 ± 0.01 0.13 ± 0.02 2.09 ± 0.30   40  
CPU 0.12 ± 0.04 0.08 ± 0.01 0.13 ± 0.04 0.09 ± 0.01 1.61 ± 0.23 37    
HIP 0.10 ± 0.01 0.09 ± 0.02 0.10 ± 0.01 0.10 ± 0.02 1.59 ± 0.39      
CTX 0.09 ± 0.01 0.11 ± 0.05 0.08 ± 0.01 0.09 ± 0.01 1.31 ± 0.30      
TH 0.08 ± 0.02 0.11 ± 0.06 0.06 ± 0.01 0.06 ± 0.01 1.11 ± 0.31      
CB 0.07 ± 0.02 0.06 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 1.00 ± 0.01      
a

Preinjection of naloxone (1 mg/kg; iv; 10 min).

b

Preinjection of U-50,488 (1 mg/kg; iv; 10 min).

c

Preinjection of JDTic (10 mg/kg; ip; 30 min).

d

Only values for significant inhibition (P < 0.041).

e

Not applicable.